Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors

Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors

A novel and potent series of ene-amides featuring azetidines has been developed as FabI inhibitors active against drug resistant Gram-positive pathogens particularly staphylococcal organisms. Most of the compounds from the series possessed excellent biochemical inhibition of Staphylococcus aureus Fa...

Full description

Bibliographic Details
Main Authors:	Takhi, M., Sreenivas, K., Reddy, C.K., Munikumar, M., Praveena, K., Sudheer, P., Rao, B.N.V.M., Ramakanth, G., Sivaranjani, J., Mulik, S., Reddy, Y.R., Narasimha Rao, K., Pallavi, R., Lakshminarasimhan, A., Panigrahi, S.K., Antony, T., Abdullah, I., Lee, Y.K., Ramachandra, M., Yusof, R., Rahman, N.A., Subramanya, H.
Published:	2018
Online Access:	http://dspace.uniten.edu.my/jspui/handle/123456789/9750

Similar Items

Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors
by: Takhi, M., et al.
Published: (2017)

Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
by: Lu, Xiaoyun, et al.
Published: (2012)

A Structural and Energetic Model for the Slow-Onset Inhibition of the Mycobacterium tuberculosis Enoyl-ACP Reductase InhA
by: Li, Huei-Jiun, et al.
Published: (2014)

Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression
by: Grandgirard, Denis, et al.
Published: (2015)

Increasing pinosylvin production in Escherichia coli by reducing the expression level of the gene fabI-encoded enoyl-acyl carrier protein reductase
by: Caheri Salas-Navarrete, et al.
Published: (2018-05-01)

Determination of the Crystal Structure and Active Residues of FabV, the Enoyl-ACP Reductase from Xanthomonas oryzae
by: Li, He, et al.
Published: (2011)

QSAR and Molecular Docking Studies of Oxadiazole-Ligated Pyrrole Derivatives as Enoyl-ACP (CoA) Reductase Inhibitors
by: Asgaonkar, Kalyani D., et al.
Published: (2014)

Correlating drug–target kinetics and in vivo pharmacodynamics: long residence time inhibitors of the FabI enoyl-ACP reductase† †Electronic supplementary information (ESI) available: Derivation of PK/PD models. See DOI: 10.1039/c6sc01000h
by: Daryaee, Fereidoon, et al.
Published: (2016)

Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors
by: da Silva Lima, Camilo Henrique, et al.
Published: (2015)

The Interactions of CPP–ACP with Saliva
by: Huq, Noorjahan Laila, et al.
Published: (2016)

2-{Hydroxy[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]methyl}acrylonitrile
by: Prasanna, C. M. Sai, et al.
Published: (2011)

An overview of peroxisome proliferator-induced hepatocarcinogenesis.
by: Rao, M S, et al.
Published: (1991)

Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat.
by: Reddy, J. K., et al.
Published: (1978)

Malignant neoplasms in rats fed lasiocarpine.
by: Rao, M. S., et al.
Published: (1978)

Immunochemical identity of peroxisomal enoyl-CoA hydratase with the peroxisome-proliferation -associated 80,000 mol wt polypeptide in rat liver
by: Reddy, MK, et al.
Published: (1981)

Optimum number of blades for maximum efficiency of centrifugal blowers
by: Y.R., REDDY, et al.
Published: (1971)

Identification of potential inhibitor targeting enoyl-acyl carrier protein reductase (InhA) in Mycobacterium tuberculosis: a computational approach
by: Shanthi, V., et al.
Published: (2013)

Remineralizing potential of CPP-ACP in white spot lesions – A systematic review
by: K Indrapriyadharshini, et al.
Published: (2018-01-01)

Prosthetic rehabilitation in patient with achalasia cardia — A rare case report
by: Kondaka, Sudheer, et al.
Published: (2016)

Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.
by: Rao, M. S., et al.
Published: (1988)

Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
by: Reddy, J K, et al.
Published: (1986)

Magnetic and nonlinear optical properties of BaTiO3 nanoparticles
by: S. Ramakanth, et al.
Published: (2015-05-01)

Novel Azetidine-Containing TZT-1027 Analogues as Antitumor Agents
by: Yan, Qi, et al.
Published: (2016)

Screening for Acyl Carrier Protein (ACP) Gene of Oil Palm (Elaeis Quineensia) Using a Synthetic ACP DNA Probe
by: Abd. Manaf, Mohamad Arif
Published: (1994)

Modeling holo-ACP:DH and holo-ACP:KR complexes of modular polyketide synthases: a docking and molecular dynamics study
by: Anand, Swadha, et al.
Published: (2012)

Shewanella oneidensis FabB: A β-ketoacyl-ACP Synthase That Works with C16:1-ACP
by: Luo, Qixia, et al.
Published: (2016)

A Suzuki type unique common fixed point theorem for two pairs of hybrid maps under a new condition in partial metric spaces
by: Rao K. P. R., et al.
Published: (2016-03-01)

An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patients
by: Manohar, Suchitra Mustur, et al.
Published: (2013)

Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase
by: Muench, Stephen P., et al.
Published: (2006)

Enoyl-CoA hydratase mediates polyhydroxyalkanoate mobilization in Haloferax mediterranei
by: Liu, Guiming, et al.
Published: (2016)

Mechanism and Substrate Recognition of Human Holo ACP Synthase
by: Bunkoczi, Gabor, et al.
Published: (2007)

Effectiveness of economic cooperation between the EU and the ACP countries
by: Ayse, Evrensel
Published: (2009)

Staphylococcus aureus but not Listeria monocytogenes adapt to triclosan and adaptation correlates with increased fabI expression and agr deficiency
by: Nielsen, Lene Nørby, et al.
Published: (2013)

Meleagrin, a New FabI Inhibitor from Penicillium chryosogenum with at Least One Additional Mode of Action
by: Zheng, Chang Ji, et al.
Published: (2013)

Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model
by: Banevicius, Mary A, et al.
Published: (2013)

Role of Probiotics in Short Bowel Syndrome in Infants and Children—A Systematic Review
by: Reddy, Vudum S., et al.
Published: (2013)

Postoperative Impairment of Airway Reflexes Reversed by Ventricular CSF Diversion in a Patient with a Trigeminal Schwannomma
by: Madhusudan, Reddy K.R, et al.
Published: (2011)

Selected novel 5'-amino-2'-hydroxy-1, 3-diaryl-2-propen-1-ones arrest cell cycle of HCT-116 in G0/G1 phase
by: Simon, Lalitha, et al.
Published: (2016)

Enoyl Coenzyme A Hydratase Domain–Containing 2, a Potential Novel Regulator of Myocardial Ischemia Injury
by: Du, Jianhai, et al.
Published: (2013)

Studies of pancreatic carcinogenesis in different animal models.
by: Scarpelli, D G, et al.
Published: (1984)